For all the nanopore enthusiasts and aficionados out there, London Calling is the highlight of the year. Taking place in May, the show is everything you’d expect from a company that takes such care with its growing community of users.
U.S. regulators have put a halt on a clinical trial planned to use CRISPR technology on sickle-cell patients due to ‘unspecified questions’, CRISPR Therapeutics said on Wednesday.
Researchers who’ve created a kidney-on-a-chip explain why these kinds of devices are an improvement over traditional ways to test new drugs.
A team of researchers has unveiled a novel statistical algorithm, capable of identifying potential disease genes in a more accurate and cost-effective way.
Japanese scientists now have permission to treat people who have heart disease with cells produced by a revolutionary reprogramming technique, which excites researchers. But some fear the therapy will be rushed to market.
Although reprogrammed viruses are commonly used in gene therapy to treat diseases, this virus can do its work without affecting healthy cells.
Fetuses with a specific, rare chromosomal aberration have a 20% risk of developmental or other brain disorder, new research shows. The work could lead to personalised diagnostics and counselling for pregnant women.
It’s been a recurring refrain: Africa still lags woefully behind the rest of the world in generating new scientific knowledge. But there are several projects that offer hope amid all the bad news.
Genetics is influencing more and more of our decisions, but we can’t make the right choices if we don’t understand it.
A new technique reveals the earliest stages of human development without the need for human embryos.